Clinical perspectives in primary nocturnal enuresis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Primary nocturnal enuresis (PNE) is prevalent among the pediatric population, but not all professionals are aware of the current research regarding the etiology and treatment of this disorder. This paper presents a broad overview of PNE, including etiology and evaluation, with a specific emphasis on treatment issues. The most current treatments (imipramine, desmopressin acetate arginine vasopressin, enuresis alarms) are discussed, including recent research on their effectiveness. In considering the recent data on long-term efficacy, overall cost, and safety, the treatment of choice appears to be the enuresis alarm for those families who are capable of following protocols. Desmopressin acetate arginine vasopressin is a safe alternative that has the advantage of quick response and ease of administration.

Original languageEnglish (US)
Pages (from-to)23-30
Number of pages8
JournalClinical pediatrics
Volume37
Issue number1
StatePublished - Feb 17 1998

Fingerprint

Nocturnal Enuresis
Enuresis
Deamino Arginine Vasopressin
Arginine Vasopressin
Imipramine
Research
Health Care Costs
Pediatrics
Safety
Population

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Clinical perspectives in primary nocturnal enuresis. / Gimpel, Gretchen A.; Warzak, William J; Kuhn, Brett R; Walburn, John Norman.

In: Clinical pediatrics, Vol. 37, No. 1, 17.02.1998, p. 23-30.

Research output: Contribution to journalArticle

@article{ec2317ea78a44ff6a1b6b104f92448d3,
title = "Clinical perspectives in primary nocturnal enuresis",
abstract = "Primary nocturnal enuresis (PNE) is prevalent among the pediatric population, but not all professionals are aware of the current research regarding the etiology and treatment of this disorder. This paper presents a broad overview of PNE, including etiology and evaluation, with a specific emphasis on treatment issues. The most current treatments (imipramine, desmopressin acetate arginine vasopressin, enuresis alarms) are discussed, including recent research on their effectiveness. In considering the recent data on long-term efficacy, overall cost, and safety, the treatment of choice appears to be the enuresis alarm for those families who are capable of following protocols. Desmopressin acetate arginine vasopressin is a safe alternative that has the advantage of quick response and ease of administration.",
author = "Gimpel, {Gretchen A.} and Warzak, {William J} and Kuhn, {Brett R} and Walburn, {John Norman}",
year = "1998",
month = "2",
day = "17",
language = "English (US)",
volume = "37",
pages = "23--30",
journal = "Clinical Pediatrics",
issn = "0009-9228",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Clinical perspectives in primary nocturnal enuresis

AU - Gimpel, Gretchen A.

AU - Warzak, William J

AU - Kuhn, Brett R

AU - Walburn, John Norman

PY - 1998/2/17

Y1 - 1998/2/17

N2 - Primary nocturnal enuresis (PNE) is prevalent among the pediatric population, but not all professionals are aware of the current research regarding the etiology and treatment of this disorder. This paper presents a broad overview of PNE, including etiology and evaluation, with a specific emphasis on treatment issues. The most current treatments (imipramine, desmopressin acetate arginine vasopressin, enuresis alarms) are discussed, including recent research on their effectiveness. In considering the recent data on long-term efficacy, overall cost, and safety, the treatment of choice appears to be the enuresis alarm for those families who are capable of following protocols. Desmopressin acetate arginine vasopressin is a safe alternative that has the advantage of quick response and ease of administration.

AB - Primary nocturnal enuresis (PNE) is prevalent among the pediatric population, but not all professionals are aware of the current research regarding the etiology and treatment of this disorder. This paper presents a broad overview of PNE, including etiology and evaluation, with a specific emphasis on treatment issues. The most current treatments (imipramine, desmopressin acetate arginine vasopressin, enuresis alarms) are discussed, including recent research on their effectiveness. In considering the recent data on long-term efficacy, overall cost, and safety, the treatment of choice appears to be the enuresis alarm for those families who are capable of following protocols. Desmopressin acetate arginine vasopressin is a safe alternative that has the advantage of quick response and ease of administration.

UR - http://www.scopus.com/inward/record.url?scp=0031883371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031883371&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 23

EP - 30

JO - Clinical Pediatrics

JF - Clinical Pediatrics

SN - 0009-9228

IS - 1

ER -